Linee guida nazionali » Diagnosi oncologica precoce

Bibliografia

  • Caplan LS and Helzlsouer KJ. Delay in breast cancer. Public Health Reviews 93, 187-214, 1992.
  • Charlson ME. Delay in the treatment of carcinoma of the breast. Surg Gynecol Obstet 160, 393-399, 1985.
  • Colbert K. The longer the delay the greater the anxiety. Delay in treatment for breat cancer. Professional Nurse, 517-520, 1994.
  • Crosland A and Jones R. Rectal bleeding: prevalence and consultation. British Medical Journal 311, 486-488, 1995.
  • Dixon A, Thornton-Holmes J, and Cheetham N. General practitioners' awareness of colorectal cancer: a 10 year review . BMJ 301, 152-153, 1990.
  • Flam F, Einhorn N, and Sjovall K. Symptomatology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol 27(53), 57, 1988.
  • Franceschi S, La Vecchia C, Gallus G, et al. Delayed diagnosis of endometrial cancer in Italy. Cancer 51, 1176-1178, 1983.
  • Fruchter RG and Boyce J. Delays in diagnosis and stage of disease in gynecologic cancer. Cancer Detect Prev 4, 481-486, 1981.
  • GIVIO (Interdisciplinary Group for Cancer Care Evaluation). Reducing diagnostic delay in breast cancer: Possible therapeutic implications. Cancer 58, 1756-1761, 1986.
  • Goodman D and Irvine T. Delay in the diagnosis and prognosis of carcinoma of the right colon. British Journal of Surgery 80, 1327-1329, 1993.
  • Greenwald HP. HMO membership, copayment, and initiation of care for cancer: a study of working adults. Am J Publ Health 1987; 7 7: 461-6.
  • Holliday H and Hardcastle J. Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet, 309-311, 1979.
  • Jones R and Dudgeon T. Time between presentation and treatment of six common cancers: a study in Devon. Journal of General Practice (42), 419-422, 1992.68
  • Katz SJ, Hislop TG, Thomas DB, and Larson EB. Delay from symptom to diagnosis and treatment of breast cancer in Washington State and British Columbia. Medical Care 31, 264-268, 1993.
  • Laroche C , Wells F, Coulden R, Stewart S, Goddard M, Lowry E et al. Improving surgical resection rate in lung cancer [see comments]. Thorax 1998; 5 3: 445-449.
  • MacAdam D. A study in general practice of the symptoms and delay patterns in the diagnosis of gastrointestinal cancer. Journal of the Royal College of General Practitioners 29, 723-729, 1979.
  • MacArthur C and Smith A. Delay in the diagnosis of colorectal cancer. Journal of the Royal College of General Practitioners 33, 159-161, 1983.
  • Menczer J, Krissi H, Chetrit A, and et al. The effect of diagnosis and treatment dealy on prognostic factors and survival in endometrial cancer. Am J Obstet Gynecol 173, 774-778, 1995.
  • Mitic WR, Perkins J. The effect of a media campaign on heart attack delay and decision times. Can. J. Public Health 1984; 7 5: 414-418.
  • Nichols S., Waters WE., Fraser JD., Wheeller MJ., and Ingham SK. Delay in the presentation of breast symptoms for consultant investigation. Community Medicine 3, 217-225, 1981.
  • Robinson E, Mohilever J, Zidan J, and Sapir D. Colorectal cancer incidence delay in diagnosis and stage of disease. Eur.J.Cancer Clin.Oncol. 22, 157-161, 1986.
  • Robinson E, Mohilever J, and Borovik R. Factors affecting delay in diagnosis of breast cancer: relationship of delay to stage of disease. Isr J Med Sci 22, 313-338, 1986.
  • Rossi S, Cinini C, Di Pietro C, Lombardi CP, Crucitti A, Bellantone R, and Crucitti F. Diagnostic delay in breast cancer: correlation with disease stage and prognosis. Tumori 76, 559-562, 1990.
  • Rowe-Jones D and Aylett S. Delay in treatment in carcinoma of colon and rectum. Lancet, 973-975, 1965.
  • Stebbing J and Nash A. Avoidable delay in the management of carcinoma of the right colon. Ann R Coll Surg Engl 77, 21-23, 1995.
  • Stubbs R and Long M. Symptom duration and pathologic staging of colorectal cancer. Journal of Surgical Oncology 12, 127-130, 1986.
  • Tennvall J, Moller T, and Attewell R. Delaying factors in primary treatment of breast cancer. Acta Chir Scand 156, 591-596, 1990.
  • Waters WE., Nichols S, Wheeller MJ., Fraser JD., Hayes AJ. Evaluation of a health education campaign to reduce the delay in women presenting with breast symptoms. Community Medicine 1983; 5: 104-108.69
  • Referral guidelines for suspected cancer. Consultation document. 1999, Department of Health, London (UK).
  • Cluzeau F, Littlejohns P, Grimshaw J, Feder G, Moran S. Development and application of a generic methodology to assess the quality of clinical guidelines. Int J Qual Health Care 1999; 1 1: 21-28.
  • Littlejohns P and Cluzeau F. Promoting the rigorous development of clinical guidelines in Europe through the creation of a common appraisal instrument, 1997. Amsterdam, 5-8 Oct, Scientific Basis for Health Services. Ref Type: Conference Proceeding.
  • Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994; 27 1: 703-707.
  • Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1994; 271: 389-391.
  • Consiglio Nazionale per le Ricerche e Associazione Italiana Ricerca sul Cancro. Consenso sugli screening in oncologia. Indirizzo per la ricerca e raccomandazioni per il Servizio Sanitario Nazionale, 1996.
  • Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectacl cancer using the faecal occult blood test, Hemoccult. BMJ 1998; 31 7: 559-565.
  • Verne JECW, Aubrey R, Love SB, Talbot IC, Northover JMA. Population based randomised study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ 1998; 31 7: 182-185.
  • Beck JR, Pauker SG. The Markov process in medical prognosis. Medical Decision Making 1983; 3: 419-458.
  • Sonnenberg FA, Beck JR. Markov models in medical decision making: A practical guide. Medical Decision Making 1993; 1 3: 322-338.
  • Linee Guida elaborate dalla Commissione oncologica nazionale, in applicazione di quanto previsto dal Piano sanitario nazionale per il triennio 1994-1996, relativo all'azione programmata "Prevenzione e cura delle malattie oncologiche", concernenti l'organizzazione della prevenzione e dell'assistenza in oncologia. Gazzetta Ufficiale (127), 1-6-1996.
  • Gray JAM. Evidence-Based Healthcare. Churchill Livingstone, 1997.
  • Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 31 8: 1728-1733.
  • Rembold CM. Number needed to screen: development of a statistic for disease screening. BMJ 1998; 31 7: 307-312.
  • Linee guida per i programmi di screening del cancro della mammella e della cervice uterina. Roma: Osservatorio Epidemiologico Regione Lazio, 1997.
  • GISCi (Gruppo Italiano Screening del Cervicocarcinoma). Indicatori e standard per la valutazione di processo dei programmi di screening del cancro del collo dell'utero. Manuale operativo. Epidemiogia e Prevenzione 1999; 2 3: Suppl.
  • Coleman D, Day N, Douglas G, Farmery E, Lynge E, Philip J et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. Eur J Cancer 1993; 29A Suppl 4: S1-38.
  • Quality Assurance Guidelines for the Cervical Screening Programme. Report of a Working party convened by the NHS Cervical Screening Programme, 1996. NHS Cervical Screening Programme.70
  • European Commission. European guidelines for quality assurance in mammography screening, 1996. Europe Against Cancer.
  • Austoker J. Gaining informed consent for screening. BMJ 1999; 31 9: 722-723.
  • Wardle J, Taylor T, Sutton S, Atkin W. Does publicity about cancer screening raise fear of cancer? Randomised trial of the psychological effect of information about cancer screening. BMJ 1999; 31 9: 1037-1038.
  • O'Connor AM, Rostom A, Fiset V, Tetroe J, Entwistle V, Llewellyn-Thomas H et al. Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ 1999; 31 9: 731-734.
  • Grilli R, Freemantle N, Minozzi S, Domenighetti G, Finer D. L'effetto dei mass media sull'uso dei servizi sanitari. Una revisione sistematica della letteratura. Epidemiologia e Prevenzione 1998; 2 2: 103-110.
  • Domenighetti G, Grilli R, Liberati A. Promoting consumers' demand for evidence-based medicine. International Journal of Technology Assessment in Health Care 1998; 1 4: 97-105.
  • Charnock D, Shepperd S, Needham G, Gann R. DISCERN: an instrument for judging the quality of written consumer health information for treatment choices. Community Health 1999; 5 3: 105-111.
  • Coulter A. A evidence-based patient information. BMJ 1998; 31 7: 225-226.
  • Shepperd S, Charnock D, Gann B. Helping patients access high quality health information. BMJ 1999; 31 9: 764-766.
  • Vahabi M, Ferris L. Improving written patient education materials: a review of the evidence. Health Education Journal 1995; 5 4: 99-106.
  • Coulter A, Entwistle V, Gilbert H. Informing patient. An assessment of the quality of patient information materials. London (UK): King's Fund, 1998.
  • Entwistle VA, Watt IS. Disseminating information about healthcare effectiveness: a survey of consumer health care information services. Quality in Health Care 1998; 7: 124-129.